FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma

FDA Approves NGS-Based Companion Diagnostic for Previously Treated IDH1-Mutated Cholangiocarcinoma CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif., Aug. 25, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to... Read more

Divestment of NDC Technologies

24 August 2021 – Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces the divestment of its NDC Technologies (‘NDC’) business. The transaction is in line with Spectris’ strategy to simplify and focus its portfolio and is the last of the divestments identified in 2019 as part of its Strategy... Read more

Danaher Announces Human Resources And Accounting Leadership Transition Plans

WASHINGTON, Aug. 24, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced that, effective April 1, 2022, Georgeann F. Couchara will succeed Angela S. Lalor as Senior Vice President, Human Resources. At that time, Ms. Lalor will move to a part time, advisory role until her retirement in the first quarter of 2023. Ms. Couchara, currently Vice President,... Read more

PerkinElmer to Present at 2021 Baird Global Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual Baird Global Healthcare Conference on Tuesday, September 14, 2021 at 10:50 a.m. ET. Steve Willoughby, vice president of investor relations of PerkinElmer, will provide an update... Read more

Shimadzu has released Py-Screener Ver.2

Screening System for Phthalate Esters and Brominated Flame Retardants Making the Difficult simple Py-Screener™ Ver. 2 is designed to screen for brominated flame retardants, such as PBBs and PBDEs, and phthalate esters in polymers. These substances are regulated under the Directive on the restriction of the use of certain hazardous substances in electrical and electronic... Read more

Danaher Announces Passing of Former President & CEO, George M. Sherman

Danaher Announces Passing of Former President & CEO, George M. Sherman WASHINGTON, Aug. 20, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that George M. Sherman, the Company’s President & Chief Executive Officer during the years 1990-2001, died earlier this week after an illness. Steven M. Rales, Danaher Chairman of the Board, commented: “All of us... Read more

Digital Science launches Dimensions Life Sciences & Chemistry

London, 19 August 2021 – Life Science Newswire – Digital Science, a technology company with a vision of a trusted and collaborative research ecosystem driving progress for all, is pleased to announce the launch of a new version of its popular Dimensions platform – Dimensions Life Sciences & Chemistry (Dimensions L&C) – focused on life sciences and chemistry research... Read more

PerkinElmer Expands Automated Mycotoxin Detection Kits Portfolio to Include All Major Mycotoxins

New MaxSignal Mycotoxin Automation Bundle enables faster time to result, lower cost per sample and increased productivity WALTHAM, Mass. – August 19, 2021 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its MaxSignal® Mycotoxin Automation Bundle. Using the new assays and automation of this bundle,... Read more

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1, 2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the first-of-its-kind VENTANA MMR RxDx Panel helps determine which solid tumour patients may benefit from GSK immunotherapy. Roche/GSK collaboration... Read more